Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn More
The development of Integrated Care Systems (ICSs) is the largest NHS reorganisation for a decade. This change aims to improve healthcare provision by integrating traditionally siloed services but comes with major organisational challenges. Significant complexity results; both in real-time changes as the NHS makes this transition, and how industry must adapt to how the NHS care will be organised, commissioned, and delivered.
This complexity is made simple by the ICS Intelligence Platform; helping clients educate their teams on the changes, identify new areas of need, and put in motion the actions to stay ahead of the game.
As the NHS transitions to commissioning care at a regional level, the population served across care settings will increase to 1–5 million, providing additional opportunities and challenges for Life Sciences.
The ICS Intelligence Platform helps you understand how ICSs vary in population size and geographic position in England, enabling you to align your commercial organisation and promotional activity with individual ICS needs.
ICSs are not just one organization; they represent a collection of new bodies, partnerships, and committees designed to address the NHS Long Term Plans.
Leveraging IQVIA’s reference data, the ICS Intelligence Platform demystifies these, showing quickly how they connect and operate together. The platform covers:
As the NHS transitions to commissioning care at a regional level, this poses additional healthcare capacity challenges that have not been tackled in the NHS’s long history. Most facets of health will be integrated, with the entire patient journey considered; so knowing the entire healthcare capacity and strain of the region will be important.
The ICS Intelligence Platform provides insights to help you:
You need to find the right stakeholders and discover the system-wide priorities that matter most to an ICS to support impactful engagement opportunities, which resonate with the customer. This type of precision engagement requires answering the questions at hand, as well as proactively identifying new ones.
By using the ICS Intelligence Platform to extract insights into ICS strategic priorities, and connecting these with emerging ICS stakeholders, you can:
With ICSs rapidly evolving and appointing new roles, it is critical to identify the emerging stakeholders in an ICS, at the right time to engage with. Through IQVIA’s proprietary OneKey database the ICS Intelligence Platform provides insights on verified ICS key decision makers, to help your commercial teams target their promotional activity to maximise effectiveness.
With over 1000 ICS-related HCPs identified at present, and hundreds added per month, the ICS Intelligence Platform provides the tools to engage with new decision-makers across roles:
Understand how ICSs demand new ways of collaborating and engaging with the NHS
Use IQVIA’s market-leading prescription data to understand the restructured NHS landscape
IQVIA's solutions to support Life Sciences engage with Integrated Care Systems in the NHS
IQVIA's programmes to support Integrated Care Systems with the delivery of the NHS Recovery and Long Term Plans
